Biotechnology News
Cutting edge news about companies engaged in the research and development of new drugs, medical devices and procedures as well as research, books and information on FDA approvals, patents and awards. Biotechnology news highlights the use of biological processes, organisms or systems to manufacture products that improve the quality of life.
AveXis Receives Orphan Drug Status from the US Food and Drug Administration (FDA) for chariSMA for the Treatment of Spinal Muscular Atrophy
AveXis Inc., a synthetic biology platform company primarily focused on developing treatments for Spinal Muscular Atrophy (SMA) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to its product scAAV9, called chariSMA to treat Spinal Muscular Atrophy... - October 04, 2014 - AveXis Inc.
The Knowledge Congress Has Scheduled a Live Webcast on Hot Topics in the Pharma Biotech Industries Live Webcast
This course offers an overview of the latest trends and best practices with respect to hot issues surrounding the Pharmaceutical and Biotech industries. A panel of thought leaders and practitioners will help firms better understand how to apply this law or business trend to their company and/or clients. Key topics include: Pharma Biotech industries 2014: An overview, Latest trends in Pharma Biotech industries, Hot topics and regulatory issues, Best practices, etc. - October 02, 2014 - The Knowledge Group
John J. Molenda, PhD, Partner, Steptoe & Johnson LLP to Speak at KG’s Hot Topics in the Pharma Biotech Industries Live Webcast
This course offers an overview of the latest trends and best practices with respect to hot issues surrounding the Pharmaceutical and Biotech industries. A panel of thought leaders and practitioners will help firms better understand how to apply this law or business trend to their company and/or clients. Key topics include: Pharma Biotech industries 2014: An overview, Latest trends in Pharma Biotech industries, Hot topics and regulatory issues, Best practices, Up-to-minute regulatory updates, etc - October 02, 2014 - The Knowledge Group
National Algae Association Claims That Algae Won't Be Grown in Washington, DC
After over 6 decades of time, and billions of dollars spent at the direction of the Department of Energy and other government agencies, one thing is for sure – algae for fuels will never be grown in Washington, D.C. "The algae production industry does not need lobbyists who have no... - October 01, 2014 - national algae asssociation
Voicebrook Announces Participation at 2014 Southeast Chairs and Administrators Conference
Company to demonstrate how its solutions address pathologist needs in a complex academic reporting environment. - September 26, 2014 - Voicebrook, Inc.
DNAe Completes Its Leadership Team with Key Operational and R&D Appointments as It Takes Forward Its DNA Diagnostic Test for Sepsis
DNA Electronics ("DNAe"), the inventors of semiconductor DNA sequencing technology and developers of a new, revolutionary point-of-need test for sepsis, today announced the completion of its leadership team with the appointment of Kevin Stearn as Operational Director, and Dr David Edington as Vice President, R&D. - September 24, 2014 - DNA Electronics
Clinical Network Services (CNS) and Ventac Partners Sign Cooperative Partnership
Clinical Network Services (CNS) an integrated service consultancy focused on product development and Ventac Partners, a life science consulting firm, today announced that they have signed a cooperative partnership agreement to provide joint service offerings in the biotech and pharma sectors in fundraising, company evolution and drug development. The partnership pools the corporate expertise of Ventac Partners with the regulatory expertise of CNS and expands the geographical reach of both. - September 22, 2014 - Ventac Partners
Creative Biomart Morning Talk for Mutagenesis Services
Creative BioMart, a world leading Biotech Company, has conducted a morning talk to discuss its mutagenesis. This talk lasted for nearly one hour. Mutagenesis is a fundamentally important DNA manipulation technique. It involves changing the base sequence of the DNA molecule, usually for the... - September 18, 2014 - Creative Biomart
Dr Frank Tomecek Receives Risk All Star Award
Emerge Diagnostics, is pleased to announce today that Frank Tomecek, MD, received the Risk All Star Award from Risk & Insurance for his groundbreaking work with Emerge Diagnostics. Risk All Stars stand out from their peers by overcoming challenges through creativity, passion, and perseverance. - September 15, 2014 - Emerge Diagnostics
Pathology Diagnostics Ltd (PDL) Wins Prestigious Biomedical Catalyst (BMC) Scheme Award
Pathology Diagnostics Ltd is one of the earliest SME recipients of the £180 million Technology Strategy Board (the UK’s Innovation Agency) Biomedical Catalyst funding programme; winning a Biomedical Catalyst feasibility award in the second round of the BMC scheme in December 2012. The... - September 12, 2014 - Pathology Diagnostics Ltd
FDA Approves PleximmuneTM for Personalized Prediction of Transplant Rejection in Children
Today the FDA announced approval of PleximmuneTM, a blood test from the Pittsburgh-based biotech company Plexision. This test predicts acute cellular rejection of transplanted livers and intestines in children. PleximmuneTM is a first-in-class test to determine a personalized rejection-risk index... - September 11, 2014 - Plexision
VIRUN® NutraBIOsciences™ Granted Patent 261124 in India, Redesigns Website, Omega-3 Summit at Supply Side West and CEO is Again Scheduled to Speak at Cal Poly Pomona
VIRUN has been granted patent number 261124 titled, Compositions Comprising a Mucoadhesive Protein and an Active Principle for Mucosal Delivery of Said Agents. Also, VIRUN has re-designed their website to include brands, a product description page, video as well as a news and PR page. Included in the newly renovated website is an events page; with the growing interest in VIRUN, such as scheduled forums, lectures, expos and webinars, it was imperative this new website share these experiences. - September 11, 2014 - VIRUN
Creative Biomart Newly Introduced Its Stable Cell Line Service
Creative Biomart today has given an announcement that they would release their new service-stable cell line service in this very day to meet their customer’s need. Stable cell lines are essential for protein and antibody and cell-based assays. But the processes required for the generation of... - September 11, 2014 - Creative Biomart
Megan Driscoll, CEO of PharmaLogics Recruiting Becomes 1 of Only 750 Other Female CEO’s on the 2014 Inc. 5000 List of America’s Fastest-Growing Private Companies
Ranked No. 2077 with a Three-Year Sales Growth of 193% - September 10, 2014 - PharmaLogics Recruiting
Xeno Diagnostics Adds Dr. Daniel Wierda as Director of Research and Development
Addition of Top Talent Strengthens Fast-Growing Indianapolis Biotech CRO - September 10, 2014 - Xeno Diagnostics, LLC
Medic East Africa: East Africa’s Largest Healthcare Exhibition and Congress Maintains Its Prominent Presence on the Continent
The Visa Oshwal Convention Centre in Nairobi will once again host the 2nd Medic East Africa Exhibition & Congress (MEA), which is the largest healthcare event in East Africa to date, and exclusively supported by the Ministry of Health. This year's event will take place from 23-25 September 2014... - September 06, 2014 - Informa Life Sciences
Sengenics Launches Sequenom’s New Non-Invasive Prenatal VisibiliT Test in Three Additional Territories in Asia
Sengenics, a leading molecular diagnostics and research company in the region, today announced the launch of VisibiliT, Sequenom's new low-cost, non-invasive, prenatal test. After successfully launching the MaterniT21 prenatal test in November 2012 in Singapore and Malaysia, Sequenom has chosen... - September 02, 2014 - Sengenics
Creative Biomart Newly Released a Bunch of Over-Expression Lysates
Official marketing staff of Creative Biomart has announced today of their new products release for over-expression lysates. According to its official announcement, this new release is mainly an enhancement of their lysates product. Nearly 9,000 of products have been added in this launch such as... - September 02, 2014 - Creative Biomart
Affinity Biologicals Presents New Health Canada & CE Marked Plasmas for Diagnostic Use and Hemostasis Research in Canada & Europe
Affinity Biologicals Inc., a leading name in diagnostics and research, especially hemostasis research, has recently announced the launching of their new Factor Deficient Plasma page that features their new Health Canada and CE Marked plasmas. - August 29, 2014 - Affinity Biologicals
NC COIN Promotes Karen Shank to Business Development Director
Pharma, Software, and Medical Technology Veteran Developing K-12 Programming, Expanding Membership Base of Nonprofit Idea Accelerator - August 27, 2014 - COIN
Creative Biomart Introduced Immobilized Enzyme Service
On August 24, 2014, Creative Biomart has introduced their novel service of immobilized enzymes. This novel service is based on a revolutionary new platform, combining affinity tag binding with inert porous materials, designed especially for biocatalysis application in any organic solvent or... - August 27, 2014 - Creative Biomart
Braasch Biotech to Participate at Informa's 9th Annual Veterinary Vaccine Conference
Braasch's Biotech's Dr. Keith Haffer to host seminar on adjuvants at Informa's Veterinary Vaccine Conference in December. - August 25, 2014 - Braasch Biotech LLC
Cheers—Creative Biomart Launches High-Throughput Protein Production
The marketing chief staff of Creative Biomart has announced today that they will release the high-throughput protein production service on this very day in the aim of helping speed up their customer’s protein production project. Protein expression is widely used in the production of... - August 22, 2014 - Creative Biomart
Creative Biomart Launches Novel Service for Protein Labeling
On August 18, Creative Biomart had launched a novel service that is site-specific and custom labeling for protein labeling. This new service includes C-terminal labeling, N-terminal labeling, and Labeling at glycosylation sites. The launch of the site-specific and custom labeling service was said... - August 22, 2014 - Creative Biomart
Affinity Biologicals Introduce Upgraded Collection of VisuLize™ Antigen ELISA Kits
ELISA, otherwise known as the enzyme-linked immunosorbent assay, is a test that detects the presence of a certain substance, generally an antigen, by monitoring antibodies and colour change. - August 21, 2014 - Affinity Biologicals
Creative Biomart Signed Industrial Enzymes Agreement
Creative Biomart signed an Industrial Enzymes Agreement with a UK Industrial giant (the name of the company is not allowed to be exposed according to the agreement). On the basis of this agreement, Creative Biomart is going to provide High-temperature Alpha-amylase for beer, Mid-temperature... - August 20, 2014 - Creative Biomart
Biological Drugs Market Will Reach USD 2, 87,139.7 Million in 2019, Globally: Persistence Market Research
Global Market Study on Biological Drugs: North America to Witness Highest Growth by 2020 - Persistence Market Research - August 19, 2014 - Persistence Market Research
Epitope Diagnostics, Inc. Introduces New 2-Hour Human ACTH ELISA Kit
Epitope Diagnostics releases a new, highly sensitive and robust human ACTH ELISA kit which can be completed in 2 hours, increasing the efficiency of clinical laboratory operations. - August 19, 2014 - Epitope Diagnostics, Inc.
MMS Holdings and Oncology Trials Insights Form Strategic Partnership to Deliver Comprehensive Oncology Support Services
MMS Holdings Inc., a global clinical research organization that focuses on regulatory submission support for the pharmaceutical, biotech and medical device industries, and Oncology Trials Insights (OTI), an organization of oncology key opinion leaders that architect superior clinical trial... - August 18, 2014 - MMS Holdings Inc.
Creative Diagnostics Expands Its Antibody Pairs Offering
By the time of the release, Creative Diagnostics has expanded its antibody pairs to over 40,000. - August 14, 2014 - Creative Diagnostics
World Genomics Market is Expected to Reach USD 22.1 Billion by 2020: by Grand View Research, Inc
Grand View Research Has Announced the latest Addition of "Global Genomics Market Trends & Forecasts To 2020" Market Research Report to Their Database. - August 14, 2014 - Grand View Research
BioGenex Opens European Office in Milan, Italy
A global market leader in fully-automated Molecular Pathology Systems, BioGenex, opens European office in Milan, Italy. - August 03, 2014 - BioGenex
BioGenex Launches New Website
A global market leader in fully-automated Molecular Pathology Systems, BioGenex, launches a new website for its customer’ worldwide. - August 03, 2014 - BioGenex
ETR Laboratories Names Lab Manager
Environmental Testing and Research Laboratories is pleased to announce that Ramakanth Ananthoji, PhD, has assumed the position of Laboratory Manager. Ananthoji comes to ETR Laboratories with a broad level of experience including leadership, management and technical work in both a laboratory and... - August 01, 2014 - Environmental Testing and Research Laboratories, Inc.
Creative Diagnostics Expands Database of Antibody Pairs
The expanding of Creative Diagnostics' database of antibody pairs could largely save the preparation time of investigators. - August 01, 2014 - Creative Diagnostics
Chinese Pharma Growth Remains Impressive in 2013-2014 Despite Challenges and Crackdowns
By large, the Chinese pharmaceutical sector still saw double-digit growth in 2013 and the first half of 2014 despite a host of challenges stemmed from slowing Chinese economy, regulatory shakeups, cost containment measures and price cuts, as well as healthcare reform turbulences, according to the... - July 25, 2014 - WiCON International Group LLC
Creative Diagnostics Announces New Big Promotion Activity for Antibodies
Creative Diagnostics's July Big Promotion is open to customers around the world. - July 22, 2014 - Creative Diagnostics
Mark Bunnage to Speak at Protein Kinases & Drug Design Conference (October 23-24, 2014 in Boston)
Mark Bunnage, Vice President, Head of Chemistry Biotherapeutics Research at Pfizer to Give a Keynote Presentation at the 3rd Protein Kinases & Drug Design Conference (October 23-24, 2014 in Boston, MA) - July 13, 2014 - GTCbio
Pathology Diagnostics Ltd (PDL) Launches New Immunofluorescence Capabilities
Pathology Diagnostics has embraced the invaluably powerful technique of immunofluorescence (IMF); utilising fluorescent-labelled antibodies to detect specific target antigens. - July 11, 2014 - Pathology Diagnostics Ltd
Hormel Foods Specialty Products Division and VIRUN®, Granted Patent No. 8,741,373
VIRUN® and the Specialty Products Division at Hormel Foods were granted Patent number 8,741,373, Composition for Non-Polar Compounds. This particular patent allows unwavering high oil load encapsulation of non-polar compounds, such as Omega-3 EPA and DHA, CoQ10, Vitamins A, D, E, K, Carotenoids such as Lutein, Beta Carotene or Astaxanthin into certain water soluble and stable foods and beverages. - July 09, 2014 - VIRUN
Recursion Pharmaceuticals Announces Funding for Rett Syndrome Research
Recursion Pharmaceuticals has received support for focused work to identify a treatment for Rett Syndrome by the Rett Syndrome Research Trust. Recursion will apply its innovative drug discovery platform immediately to investigate the gene MECP2 in an effort to identify new therapeutics for the condition. - July 09, 2014 - Recursion Pharmaceuticals
Jianxin Zhang, Sanofi Pasteur, to Speak at Protein-Protein Interaction, Oct. 23-24, 2014 in Boston
Jianxin Zhang, Deputy Director of Protein Characterization at Sanofi Pasteur to Speak at 2nd Protein-Protein Interaction Conference, October 23-24, 2014 in Boston, MA. - July 06, 2014 - GTCbio
Nic Angell at Amgen to Speak at Protein Expression, Purification, Characterization Oct 23-24, 2014
Nic Angell, Principal Scientist, Process Development at Amgen to Speak at Protein Expression, Purification & Characterization Conference, October 23-24, 2014 in Boston, MA. - July 05, 2014 - GTCbio
Nathanael Gray to Speak at 3rd Protein Kinases & Drug Design Conference (October 23-24, 2014 in Boston, MA)
Nathanael Gray, Professor, Biological Chemistry and Molecular Pharmacology, Dana Farber Cancer Institute, Harvard Medical School to Give a Featured Presentation at the 3rd Protein Kinases & Drug Design Conference (Oct 23-24, 2014 in Boston, MA). - July 05, 2014 - GTCbio
Affinity Biologicals Now Offers a Variety of Elisa Kits Aimed at Thrombosis Research
Significant New Innovations by Affinity Biologicals Promise to Greatly Extend Assay Sensitivity and ELISA’s Range of Capabilities - July 04, 2014 - Affinity Biologicals
A Lay Person's Guide to the Hobby Lobby Decision
Today, Saltbox Consulting published A Lay Person's Guide to the Hobby Lobby Decision. The guide is designed to help non-lawyers understand the Hobby Lobby decision, which the Supreme Court released on June 30, 2014. It explains in plain English what the issues were, how the Court decided them and... - July 02, 2014 - Saltbox Consulting
Pathology Diagnostics Ltd (PDL) Biomarker Test Portfolio and Advanced Staining Capabilities Show CAGR of 50%
Due to the recent rapid growth of Pathology Diagnostics Ltd (PDL), the advanced laboratory staining biomarker test portfolio of the organisation has grown at an extremely impressive rate, with the number of biomarkers validated now reaching over 370 for immunohistochemistry (IHC) and... - June 27, 2014 - Pathology Diagnostics Ltd
AveXis Announces Dosing of First Patient for Gene Transfer Clinical Trial for Spinal Muscular Atrophy Type 1 at Nationwide Children’s Hospital
AveXis, Inc., a synthetic biology platform company, today announced that the first patient in the Gene Transfer Clinical Trial for Spinal Muscular Atrophy Type 1 has now been enrolled and dosed by Nationwide Children’s Hospital. This trial utilizes chariSMA, the gene therapy product developed... - June 26, 2014 - AveXis Inc.
BioClosure(R) Container Seals from AdvantaPure(R) Now Available in Silicone and TPE for Glass, Metal or Plastic Containers
Container closures made not only from silicone but now from AdvantaFlex TPE are available from high purity tubing manufacturer AdvantaPure. Called BioClosures, the products provide a sure seal for containers used in biopharmaceutical and other critical industries. TPE offers advantages over silicone such as lower absorption rates, along with the benefit of being free of silicone oils. When used as single use components, TPE BioClosures reduce contamination risks and cleaning requirements. - June 25, 2014 - NewAge Industries, Inc.
Dr. William D. Bowers Awarded Certification by ABVLM
Dr. William D. Bowers is awarded an exclusive, ten-year certification to elite medical practitioners from the American Board of Venous & Lymphatic Medicine (ABVLM) in the field of Venous & Lymphatic Medicine. - June 24, 2014 - Bowers Vein Institute